Abstract:Background: Gastric cancer (GC) is one of the global malignant tumors with high incidence and poor prognosis. Exploring new GC molecular markers is important to improve GC prognosis. Transmembrane protein 200A (TMEM200A) is a member of the family of transmembrane proteins (TMEM). This study is the first to investigate the potential function of TMEM200A and its relationship with immune infiltration in GC. Methods: The differential expression of TMEM200A was determined through the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The receiver operating characteristic (ROC) curve was drawn to assess the diagnostic value of TMEM200A for GC. The relationship between TMEM200A and the clinical characteristics of patients with GC was investigated using the Wilcoxon test and the Kruskal-Wallis test. The effect of TMEM200A on overall survival (OS) was identified using the Kaplan-Meier method, the Log-rank test, the univariate/multivariate Cox regression analysis, and the nomogram prediction model. The co-expressed genes and gene set enrichment analysis (GSEA) were used to explore the potential biological functions of TMEM200A. We used the Tumor Immune Estimation Resource (TIMER) database and the ssGSEA algorithm to estimate the relationship between TMEM200A and immune cell infiltration. Furthermore, we investigated the correlation of TMEM200A with immune checkpoint/immune cell surface markers using the TCGA-STAD data set. Finally, we identified prognosis-related methylation sites in TMEM200A using MethSurv. Results: TMEM200A was highly expressed in GC tissues. TMEM200A had a good diagnostic value for GC. High expression of TMEM200A may shorten the OS of GC patients and may be an independent risk factor for OS in GC patients. TMEM200A participates in the construction of a predictive model with a good predictive effect on the survival rate of GC patients at 1, 3, and 5 years. Co-expressed genes and GSEA indicated that TMEM200A may be an adhesion molecule closely associated with tumor invasion and metastasis. In addition, TMEM200A may be significantly associated with immune cell infiltration and immune checkpoint expression. We also found that TMEM200A contains three methylation sites associated with a poor prognosis. Conclusion: Upregulated TMEM200A may be a promising prognostic marker for GC and is closely associated with the tumor microenvironment (TME).

Tmem16a Overexpression Contributes To Tumor Invasion And Poor Prognosis Of Human Gastric Cancer Through Tgf-Beta Signaling

TMEM200A is a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer.

High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer

TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target

Differential Expression of COL6 Family is a Potential Tumor Marker for Predicting Gastric Cancer

Overexpressed MAGP1 is Associated with a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer

Tissue Transglutaminase-2 Promotes Gastric Cancer Progression Via the ERK1/2 Pathway.

Cxcl16 Promotes Gastric Cancer Tumorigenesis Via Adam10-Dependent Cxcl16/Cxcr6 Axis And Activates Akt And Mapk Signaling Pathways

Pan-cancer analysis of TMEM45A and exploration of its prognostic value and mechanism in gastric cancer

[Expression of TMEM16A in Gastric Carcinoma and Its Clinical Implications].

Expression Of Tmem16a In Colorectal Cancer And Its Correlation With Clinical And Pathological Parameters

Abstract 945: Tissue Tranglutaminase-2 Promotes Gastric Cancer Progression Via ERK1/2 Pathway

MMP16 is a Marker of Poor Prognosis in Gastric Cancer Promoting Proliferation and Invasion

Transmembrane Protein 106A is Silenced by Promoter Region Hypermethylation and Suppresses Gastric Cancer Growth by Inducing Apoptosis.

MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway

LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion Via the PI3K/Akt Signaling Pathway

TNFRSF11B activates Wnt/-catenin signaling and promotes gastric cancer progression

Transducin (Β)-Like 1 X-linked Receptor 1 Promotes Gastric Cancer Progression Via the ERK1/2 Pathway

TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis

Upregulation of Family with Sequence Similarity 83 Member D Expression Enhances Cell Proliferation and Motility Via Activation of Wnt/β-catenin Signaling and Predicts Poor Prognosis in Gastric Cancer

CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.